Skip to content
★ Sign in to follow
AM
Insider activity · 24 months5 buys0 salesCumulative net flow
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€48k
▼ Sales (0 ops.)
—

Latest filing published 06 Nov 2026 for Indoco Remedies Limited, €12k.

Filing timeline

BuySale
Aditi M. Panandikar

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 09 Sept 2026 · 61 days ago · €11k
    -16.1%
    Entry ₹254.25 · Close 04 Nov 2026 ₹213.43
  • Filed 31 Aug 2026 · 70 days ago · €11k
    -12.5%
    Entry ₹243.84 · Close 04 Nov 2026 ₹213.43

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Aditi M. Panandikar: trading record in brief

Aditi M. Panandikar is a declared insider of Indoco Remedies Limited, with filings sourced from SEBI (PIT + SAST). Over a trading history stretching from 31 August 2026 to 6 November 2026, the count stands at 5 filings.

No open-market sale appears; the market trades are 5 purchases worth €48k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Half of the purchases are above €11k and half below. Relative to company size, the median is 0.0048% of market cap (4 purchases with a known value). Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 6 November 2026 came the latest disclosure, an open-market purchase for €12k in Indoco Remedies Limited. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Aditi M. Panandikar

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    1M INR0SEBI
    5,800 shares@ ₹216.70EquityMarket PurchaseSEBI:b4f8088ce5f13672e2a8d4111d66b616a9a53993
    Canonical exit: 4 Feb 2027 (T+90)
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    643,500 INR33SEBI
    3,000 shares@ ₹214.500.0033% mcap2.8% of flowEquityMarket PurchaseSEBI:10f6b1f2850a7255f011cc39ba672b8d44ec8cef
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    836,597 INR31SEBI
    4,000 shares@ ₹209.100.0043% mcap3.8% of flowEquityMarket PurchaseSEBI:71d62755519e4877239339459063684e5ba222d1
    Canonical exit: 1 Feb 2027 (T+90)
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    1M INR36SEBI
    4,970 shares@ ₹235.700.0053% mcap5.2% of flowEquityMarket PurchaseSEBI:1c397555ab44576ea413c63f88c16e4f986ed6bf
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    1M INR29SEBI
    5,000 shares@ ₹244.800.0061% mcap5.5% of flowEquityMarket PurchaseSEBI:4e4ee6c5dffe21ae7ab420976d3a8368816b1e63
    Canonical exit: 29 Nov 2026 (T+90)

5 of 5 declarations